This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Cystoid Macular Edema
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Prospective, randomized, double-masked, placebo-controlled clinical study to define the effective use of a topical non-steroidal anti-inflammatory drug added to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic cystoid macular edema.

Provided treatments

  • Drug: Nepafenac 0.3%
  • Drug: Saline Solution
Tris trial is registered with FDA with number: NCT03025945. The sponsor of the trial is Intuor Technologies, Inc. and it is looking for 1497 volunteers for the current phase.
Official trial title:
Pseudophakic Cystoid Macular Edema Prevention and Risk Factors; Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo